Planning the Microcycle in Elite Football: To Rest or Not to Rest?


Journal

International journal of sports physiology and performance
ISSN: 1555-0273
Titre abrégé: Int J Sports Physiol Perform
Pays: United States
ID NLM: 101276430

Informations de publication

Date de publication:
01 Mar 2023
Historique:
received: 12 04 2022
revised: 11 11 2022
accepted: 11 11 2022
pubmed: 4 1 2023
medline: 4 3 2023
entrez: 3 1 2023
Statut: epublish

Résumé

To examine the association between the programming of days off (ie, no pitch training, days off feet) within turnarounds of varying length and injury rate in elite soccer. Retrospective data from 56 team seasons of players belonging to 18 elite teams performing in top leagues including the English Premier League, Italian Serie A, Bundesliga, Scottish Premiership, Major League Soccer, and the Dutch Eredivisie from January 2018 to December 2021 were analyzed (total of 1578 players, 2865 injuries, 2859 noninternational matches, and 12,939 training-session days). The turnarounds examined lasted from 3 to 8 days. Only injuries with ≥3-day time loss were retained for analysis. The authors then looked at the injury rate within each microcycle in relation to the presence of a day off or not and its programming sequences in relation to the previous match (ie, day off at D + 1 vs D + 2 for the day after the match or the following, respectively). During 3- and 7-day turnarounds, the sequences including the day off feet at D + 2 were associated with 2 to 3 times lower overall noncontact injury rates than the other programming sequences (Cohen d: 0.9-2.7). For the other turnarounds, the differences between the sequences were unclear. The programming of a day off (or at least "off feet") at D + 2 may be associated with moderately to largely lower incidence of noncontact injuries, especially during 3- and 7-day turnarounds.

Identifiants

pubmed: 36596310
doi: 10.1123/ijspp.2022-0146
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-299

Auteurs

Martin Buchheit (M)

Kitman Labs, Dublin,Ireland.
Lille OSC, Lille,France.
HIIT Science, Revelstoke, BC,Canada.

Karim Hader (K)

Kitman Labs, Dublin,Ireland.

Derek McHugh (D)

Kitman Labs, Dublin,Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH